View Clinical Trial (Medical Research Study)
Developing Biomarkers for Fibromyalgia - NCT00932061-48106(Clinical Trial 300751)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Ann Arbor |
|
State:
|
|
MI |
| Zip Code: |
|
48106 |
| Conditions: |
|
Fibromyalgia |
| Purpose: |
|
The hypothesis of this study is that biological markers are present in the body that are
good indicators of chronic pain. Eligible participants will be assessed at baseline and
after receiving a series of acupuncture or "sham" acupuncture (something that resembles, but
is not, active acupuncture) sessions. If the subject qualifies for the investigators'
research and are subsequently enrolled in this study, they will be randomly assigned (like
the flip of a coin) to one of these two groups. Acupuncture, as previously shown by this
group, leads to improvements in both clinical and evoked pain associated with fibromyalgia.
The study involves two magnetic resonance imaging (MRI) brain scans, one at the beginning
and one at the end of the study. Another optional portion of the study would involve 2 PET
(positron emission tomography) scans of the subject's brain, one at the beginning and one at
the end of the study; this type of scan allows us to get more specific information about the
subject's brain function during an acupuncture session.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
Inclusion Criteria for Fibromyalgia Volunteers:
- Has met American College of Rheumatology (1990) criteria for the diagnosis of
fibromyalgia for at least 1 year
- Chronic pain more than 50% of days
- Willing to limit introduction of any new medications or treatments for fibromyalgia
during the study
- Able to attend study visits up to three times weekly
- Right-handed
- Be capable of giving written informed consent
Inclusion Criteria for Healthy Volunteers:
- Willing to refrain from alcohol intake for 48 hours prior to brain scans
- Be right handed
- Be capable of giving written informed consent
PET Inclusion Criteria:
- Willing to refrain from alcohol intake 48 hours prior to brain scans
- Capable of giving written consent
Exclusion Criteria:
Exclusion Criteria for Fibromyalgia Volunteers:
- Knowledge that could prevent "blinding" of the participant to the study
interventions (including previous acupuncture treatment)
- Presence of a known coagulation abnormality, thrombocytopenia, or bleeding diathesis
that may preclude the safe use of acupuncture
- Autoimmune or inflammatory disease (in addition to fibromyalgia) that causes pain
(e.g., rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel
disease)
- Daily use of narcotic pain-relievers
- History of substance abuse
- Simultaneous participation in other therapeutic trials
- Pregnant or breastfeeding
- Current severe psychiatric illness (e.g., schizophrenia, major depression with
suicidal ideation)
- Condition that may make exposure to fMRI medically inadvisable
- Any condition that may prevent satisfactory completion of the study protocol
Exclusion for Healthy Volunteers:
- Autoimmune or inflammatory disease (in addition to fibromyalgia) that causes pain
(e.g., rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel
disease)
- Having met the ACR criteria for FM
- Simultaneous participation in other therapeutic trials
- Pregnant or breastfeeding
- Current severe psychiatric illness (e.g., schizophrenia, major depression with
suicidal ideation)
- Condition that may make exposure to fMRI medically inadvisable
- Any condition that may prevent satisfactory completion of the study protocol
PET Exclusion Criteria:
- Meets any of the fMRI exclusion criteria
- Current major depression
- Condition that may make exposure to PET medically inadvisable |
|
|
|
| Study is available at: |
|
University of Michigan, Chronic Pain and Fatigue Research Center Ann Arbor, MI 48106 United States
Primary Contact: Craig Urwin, B.S. Email: craijose@umich.edu Phone: 734-998-7023
Secondary Contact: Craig Urwin, B.S Email: craijose@umich.edu Phone: 734-998-7023 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|